Company news
Ekf Diagnostics Holdings Plc (LSE:EKF) news
Every Ekf Diagnostics Holdings Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
H1 2026 Trading Update
July 30, 2026
Long Term Incentive Plan Award
May 20, 2026
AGM statement & positive Q1 trading update
May 19, 2026
Board Changes
April 27, 2026
Posting of Annual Report & Notice of AGM
April 24, 2026
Acquisition of assets from Beep Insights
April 13, 2026
Share Buyback
April 10, 2026
Full year results
March 24, 2026
Holding(s) in Company
March 19, 2026
Notice of Results
March 5, 2026
Three-year Hematology purchasing agreement
March 3, 2026
Total Voting Rights
March 2, 2026
Share Buyback Programme
February 19, 2026
Share Buyback & Completion of Buyback Programme
February 2, 2026
FY 2025 Trading Update
January 27, 2026
Executive Chair share purchase
December 16, 2025
Cancellation of Treasury Shares & TVR
December 8, 2025
Share Buyback & Extension of Buyback Programme
October 21, 2025
Share Buyback (Replacement)
October 20, 2025
Long Term Incentive Plan
September 16, 2025
Notice of interim results
September 10, 2025
Hematology contracts signed worth EUR 4.65m
August 26, 2025
H1 2025 Trading Update
July 28, 2025
Additional Share Buyback Programme
May 21, 2025
Result of AGM and Voting Results
May 20, 2025
Share Buyback & Completion of Share Buyback Prog.
May 13, 2025
Posting of AR&A & Notice of AGM
April 28, 2025
Director/PDMR Shareholding
March 26, 2025
Appointment of CEO
March 25, 2025
Notice of Results & Investor Presentations
March 6, 2025
FY 2024 Trading Update
January 29, 2025
Half-year Report
September 17, 2024
Notice of Results and Investor Presentation
September 3, 2024
Trading Update
July 24, 2024
Upgraded Product launch and Contract Wins
July 18, 2024
AGM Statement & Positive Q1 update (replacement)
May 14, 2024
Final Results
March 20, 2024
Investor Presentation – Revised start time
March 15, 2024
Opening of new US LS Manufacturing Facility
October 26, 2023
Interim results
September 26, 2023
Notice of Results & Investor Presentation
September 14, 2023
Appointment of CFO
September 12, 2023
Directorate Change
June 28, 2023
Enzyme fermentation capacity expansion progress
June 20, 2023
Distribution of shares in Verici Dx plc
May 24, 2023
AGM Statement
May 17, 2023
Successful quality management audits
May 3, 2023
Disposal of ADL Health
March 23, 2023
Trading update
February 6, 2023
Change of Adviser
January 9, 2023